IPSWICH, Mass., Aug. 19, 2014 /PRNewswire/ — New England Biolabs, Inc. (NEB®) today announced that NEB has exclusively in-licensed rights from Genomic Health, Inc. to its technology for the depletion of abundant RNAs, which is instrumental to performing sensitive RNA-seq experiments ...
Read More »